Arpad Fabian-kovacs

Array ( [id] => 6236893 [patent_doc_number] => 20100267803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Regulators Of Fat Metabolism As Anti-Cancer Targets' [patent_app_type] => utility [patent_app_number] => 12/613953 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20537 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267803.pdf [firstpage_image] =>[orig_patent_app_number] => 12613953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236892 [patent_doc_number] => 20100267802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'DELIVERY METHOD' [patent_app_type] => utility [patent_app_number] => 12/610330 [patent_app_country] => US [patent_app_date] => 2009-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15728 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267802.pdf [firstpage_image] =>[orig_patent_app_number] => 12610330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808091 [patent_doc_number] => 20120059045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'METHODS OF USING OLIGOMERIC COMPOUNDS COMPRISING 2\'-SUBSTITUTED NUCLEOSIDES' [patent_app_type] => utility [patent_app_number] => 13/125560 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23271 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059045.pdf [firstpage_image] =>[orig_patent_app_number] => 13125560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744868 [patent_doc_number] => 20120022245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'FOLATE TARGETING OF NUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/124408 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 43106 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022245.pdf [firstpage_image] =>[orig_patent_app_number] => 13124408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568089 [patent_doc_number] => 20110288152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING' [patent_app_type] => utility [patent_app_number] => 13/124448 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21800 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288152.pdf [firstpage_image] =>[orig_patent_app_number] => 13124448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314748 [patent_doc_number] => 20100112042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics' [patent_app_type] => utility [patent_app_number] => 12/580250 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 48486 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112042.pdf [firstpage_image] =>[orig_patent_app_number] => 12580250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167881 [patent_doc_number] => 20110196020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'TREATMENT OF CHRONIC FATIGUE SYNDROME USING SELECTIVE AGONISTS OF TOLL-LIKE RECEPTOR 3 (TLR3)' [patent_app_type] => utility [patent_app_number] => 12/998339 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8902 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196020.pdf [firstpage_image] =>[orig_patent_app_number] => 12998339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929950 [patent_doc_number] => 20110039909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'METHODS AND MATERIALS FOR REDUCING GLI2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/578304 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11594 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039909.pdf [firstpage_image] =>[orig_patent_app_number] => 12578304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497642 [patent_doc_number] => 20100093987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Inhibitor Nucleic Acids' [patent_app_type] => utility [patent_app_number] => 12/576146 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23070 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093987.pdf [firstpage_image] =>[orig_patent_app_number] => 12576146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015763 [patent_doc_number] => 20110223656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'MicroRNAs and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/565693 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15268 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223656.pdf [firstpage_image] =>[orig_patent_app_number] => 12565693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375819 [patent_doc_number] => 20100076057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'TARGET DNA INTERFERENCE WITH crRNA' [patent_app_type] => utility [patent_app_number] => 12/565589 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11491 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076057.pdf [firstpage_image] =>[orig_patent_app_number] => 12565589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645156 [patent_doc_number] => 20100227908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'DIAGNOSTIC, PROGNOSTIC AND TREATMENT METHODS' [patent_app_type] => utility [patent_app_number] => 12/564848 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14534 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227908.pdf [firstpage_image] =>[orig_patent_app_number] => 12564848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352709 [patent_doc_number] => 20100331389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides' [patent_app_type] => utility [patent_app_number] => 12/586281 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29013 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331389.pdf [firstpage_image] =>[orig_patent_app_number] => 12586281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163496 [patent_doc_number] => 20110160288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'OIP5 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/061105 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 34990 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160288.pdf [firstpage_image] =>[orig_patent_app_number] => 13061105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501963 [patent_doc_number] => 20110263679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/061098 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31791 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263679.pdf [firstpage_image] =>[orig_patent_app_number] => 13061098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663749 [patent_doc_number] => 20110313018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'CANCER RELATED GENE, LGN/GPSM2' [patent_app_type] => utility [patent_app_number] => 13/061123 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35479 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313018.pdf [firstpage_image] =>[orig_patent_app_number] => 13061123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372799 [patent_doc_number] => 20100080815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'MN Gene and Protein' [patent_app_type] => utility [patent_app_number] => 12/543026 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 30284 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080815.pdf [firstpage_image] =>[orig_patent_app_number] => 12543026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6578289 [patent_doc_number] => 20100047336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION' [patent_app_type] => utility [patent_app_number] => 12/542635 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11156 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047336.pdf [firstpage_image] =>[orig_patent_app_number] => 12542635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720931 [patent_doc_number] => 20120010266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER' [patent_app_type] => utility [patent_app_number] => 13/061118 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 46505 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010266.pdf [firstpage_image] =>[orig_patent_app_number] => 13061118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479512 [patent_doc_number] => 20100041736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Isolated MCPIP and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/539907 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13846 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041736.pdf [firstpage_image] =>[orig_patent_app_number] => 12539907 [rel_patent_id] =>[rel_patent_doc_number] =>)